Top Biotech Stocks
Loading...
Loading...
1,083
Link to this comment:
Share to:
Loading...
- 5:07All or Nothing Play for Todayby wallstreetmedia1,481 views
- 8:33Stock Newsby wallstreetmedia170 views
- 5:16Today's CEO videosby wallstreetmedia197 views
- 2:53This Morning's CEO Newsby wallstreetmedia110 views
- 4:06CTIC - Cell Therapeutics, Inc. techincal chart...by PASQUALEWW11,275 views
- 7:26Verisante's early skin cancer detection technol...by verisante2,029 views
- 3:18CTIC Introductionby cticaustralia1,336 views
- 4:51How To Trade Biotech Stocks Instructional DVD P...by timothysykesdotcom2,025 views
- 2:48Small, Undervalued Biotech Stocks Ripe for the ...by AlfordCooper887 views
- 11:08How to invest in biotech stocksby wallstreetmedia747 views
- 8:12Viral Genetics VRAL - Biotech Stocks - Mobile H...by thebullreport413 views
- 7:09Improved cancer therapyby wallstreetmedia4,365 views
- 9:00Market Wake Up Call - Biotech and Medical Stock...by TheOxfordClub293 views
- 6:31Biotech stock for your basketby wallstreetmedia355 views
- 7:26A Look At Some Hot Biotech Penny Stocks By Timo...by timothysykesdotcom7,357 views
- 5:43UOC CTIC FINALby Capacitaciodigital101 views
- 2:29Novavax - MCCC 2011 Verl Zanders Emerging Busin...by MCCCVideos44 views
- 2:19Top 5 Fast-Growth Stocksby TheStreetTV22,943 views
- 25:22Collaborations and co-development / John Trizzi...by vaccinenation25 views
- 7:59Daily Penny Stock Alerts (www.hypergrowthstock....by TheHypergrowthstock47 views
Novavax is nothing but a Bio Weapons Lab. It is most likely responsible for bio engineering the new H1N1 Flu Strain at which it released on the people of Mexico and soon spread through out the World. Baxter Labs is one who got caught sending the bird flu virus to 17 countries in the form of a vaccine.There jobs are to make you sick so they can profit from it. This news was kept under wraps and was not even mentioned in the USA.
mwcdx 2 years ago
FDA Accepts to File Cell Therapeutics' New Drug Application for Pixantrone
vb6josh 2 years ago
SEATTLE, Aug. 24 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted and has filed for review the Company's New Drug Application (NDA) for pixantrone as treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL). A Prescription Drug User Fee Act (PDUFA) date will be established by the FDA regarding the review of the pixantrone NDA by September 4th 2009.
vb6josh 2 years ago
explain
BakersBoyz 2 years ago
I cant wait for August 7, 2009. Priority Review request from FDA answer should be in.
CTIC all the way!!!
vb6josh 2 years ago
i liked this video :)
CAN SOMEONE PLEASE TALK TO ME Gf
Balthazor92 3 years ago